Health Care·Health Care Equipment·$32.0B
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.68 | N/A | +5.59% |
| Revenue | N/A | N/A | N/A |
management commentary, guidance changes, and full analysis available with Pro.
| EPS | $0.68 | N/A | +5.59% |
| Revenue | N/A | N/A | N/A |
Tone: Cautiously Optimistic
Management expressed satisfaction with the EPS results, highlighting ongoing efforts in innovation. They emphasized a commitment to growth despite not providing specific guidance.
We are pleased with our EPS performance this quarter.
Our focus remains on innovation and market expansion.
ResMed's earnings report shows a positive surprise in EPS, indicating better-than-expected profitability. The stock's slight increase of 0.36% reflects investor confidence in the company's performance. However, the lack of revenue data and guidance leaves some uncertainty about future growth prospects.
AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.
No charge today · Auto-bills $8/mo after 7 days · Cancel anytime
NORFOLK SOUTHN CORP
Jul 27, 2015